Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.

Despite its side-effects, docetaxel (DTX) remains a first-line treatment against castration resistant prostate cancer (CRPC). Therefore, strategies to increase its anti-tumor efficacy and decrease its side effects are critically needed. Targeting of the constitutive endoplasmic reticulum (ER) stress...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aditi Mathur, Zakaria Y Abd Elmageed, Xichun Liu, Mikhail L Kostochka, Haitao Zhang, Asim B Abdel-Mageed, Debasis Mondal
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c576fcb9a84b473ea65d5f1e6222c0e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c576fcb9a84b473ea65d5f1e6222c0e2
record_format dspace
spelling oai:doaj.org-article:c576fcb9a84b473ea65d5f1e6222c0e22021-11-25T06:04:45ZSubverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.1932-620310.1371/journal.pone.0103109https://doaj.org/article/c576fcb9a84b473ea65d5f1e6222c0e22014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25121735/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Despite its side-effects, docetaxel (DTX) remains a first-line treatment against castration resistant prostate cancer (CRPC). Therefore, strategies to increase its anti-tumor efficacy and decrease its side effects are critically needed. Targeting of the constitutive endoplasmic reticulum (ER) stress in cancer cells is being investigated as a chemosensitization approach. We hypothesized that the simultaneous induction of ER-stress and suppression of PI3K/AKT survival pathway will be a more effective approach. In a CRPC cell line, C4-2B, we observed significant (p<0.005) enhancement of DTX-induced cytotoxicity following coexposure to thapsigargin and an AKT-inhibitor. However, since these two agents are not clinically approved, we investigated whether a combination of nelfinavir (NFR) and curcumin (CUR), known to target both these metabolic pathways, can similarly increase DTX cytotoxicity in CRPC cells. Within 24 hrs post-exposure to physiologic concentrations of NFR (5 µM) and CUR (5 µM) a significantly (p<0.005) enhanced cytotoxicity was evident with low concentration of DTX (10 nM). This 3-drug combination rapidly increased apoptosis in aggressive C4-2B cells, but not in RWPE-1 cells or in primary prostate epithelial cells (PrEC). Comparative molecular studies revealed that this 3-drug combination caused a more pronounced suppression of phosphorylated-AKT and higher induction in phosphorylated-eIF2α in C4-2B cells, as compared to RWPE-1 cells. Acute exposure (3-9 hrs) to this 3-drug combination intensified ER-stress induced pro-apoptotic markers, i.e. ATF4, CHOP, and TRIB3. At much lower concentrations, chronic (3 wks) exposures to these three agents drastically reduced colony forming units (CFU) by C4-2B cells. In vivo studies using mice containing C4-2B tumor xenografts showed significant (p<0.05) enhancement of DTX's (10 mg/kg) anti-tumor efficacy following coexposure to NFR (20 mg/kg) & CUR (100 mg/kg). Immunohistochemical (IHC) analyses of tumor sections indicated decreased Ki-67 staining and increased TUNEL intensity in mice exposed to the 3-drug combination. Therefore, subverting ER-stress towards apoptosis using adjuvant therapy with NFR and CUR can chemosensitize the CRPC cells to DTX therapy.Aditi MathurZakaria Y Abd ElmageedXichun LiuMikhail L KostochkaHaitao ZhangAsim B Abdel-MageedDebasis MondalPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 8, p e103109 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Aditi Mathur
Zakaria Y Abd Elmageed
Xichun Liu
Mikhail L Kostochka
Haitao Zhang
Asim B Abdel-Mageed
Debasis Mondal
Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
description Despite its side-effects, docetaxel (DTX) remains a first-line treatment against castration resistant prostate cancer (CRPC). Therefore, strategies to increase its anti-tumor efficacy and decrease its side effects are critically needed. Targeting of the constitutive endoplasmic reticulum (ER) stress in cancer cells is being investigated as a chemosensitization approach. We hypothesized that the simultaneous induction of ER-stress and suppression of PI3K/AKT survival pathway will be a more effective approach. In a CRPC cell line, C4-2B, we observed significant (p<0.005) enhancement of DTX-induced cytotoxicity following coexposure to thapsigargin and an AKT-inhibitor. However, since these two agents are not clinically approved, we investigated whether a combination of nelfinavir (NFR) and curcumin (CUR), known to target both these metabolic pathways, can similarly increase DTX cytotoxicity in CRPC cells. Within 24 hrs post-exposure to physiologic concentrations of NFR (5 µM) and CUR (5 µM) a significantly (p<0.005) enhanced cytotoxicity was evident with low concentration of DTX (10 nM). This 3-drug combination rapidly increased apoptosis in aggressive C4-2B cells, but not in RWPE-1 cells or in primary prostate epithelial cells (PrEC). Comparative molecular studies revealed that this 3-drug combination caused a more pronounced suppression of phosphorylated-AKT and higher induction in phosphorylated-eIF2α in C4-2B cells, as compared to RWPE-1 cells. Acute exposure (3-9 hrs) to this 3-drug combination intensified ER-stress induced pro-apoptotic markers, i.e. ATF4, CHOP, and TRIB3. At much lower concentrations, chronic (3 wks) exposures to these three agents drastically reduced colony forming units (CFU) by C4-2B cells. In vivo studies using mice containing C4-2B tumor xenografts showed significant (p<0.05) enhancement of DTX's (10 mg/kg) anti-tumor efficacy following coexposure to NFR (20 mg/kg) & CUR (100 mg/kg). Immunohistochemical (IHC) analyses of tumor sections indicated decreased Ki-67 staining and increased TUNEL intensity in mice exposed to the 3-drug combination. Therefore, subverting ER-stress towards apoptosis using adjuvant therapy with NFR and CUR can chemosensitize the CRPC cells to DTX therapy.
format article
author Aditi Mathur
Zakaria Y Abd Elmageed
Xichun Liu
Mikhail L Kostochka
Haitao Zhang
Asim B Abdel-Mageed
Debasis Mondal
author_facet Aditi Mathur
Zakaria Y Abd Elmageed
Xichun Liu
Mikhail L Kostochka
Haitao Zhang
Asim B Abdel-Mageed
Debasis Mondal
author_sort Aditi Mathur
title Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
title_short Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
title_full Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
title_fullStr Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
title_full_unstemmed Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
title_sort subverting er-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/c576fcb9a84b473ea65d5f1e6222c0e2
work_keys_str_mv AT aditimathur subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
AT zakariayabdelmageed subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
AT xichunliu subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
AT mikhaillkostochka subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
AT haitaozhang subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
AT asimbabdelmageed subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
AT debasismondal subvertingerstresstowardsapoptosisbynelfinavirandcurcumincoexposureaugmentsdocetaxelefficacyincastrationresistantprostatecancercells
_version_ 1718414247217594368